Skip to main content

News and Media Releases

In the News

Media Releases

Proprietary Cannabis Growing Technology
ABcann Medicinals Inc. was one of the first companies to obtain a production license under the Marijuana for Medical Purposes Regulations..
B-TV - Wednesday October 12, 2017
New marijuana entrant ABcann aiming for consistency in products
ABcann Global, a Canadian licensed medical marijuana producer, began trading on the Venture in May. We check in with Aaron Keay, CEO with ABcann Global, on how the company intends to scale up production.
BNN - Wednesday October 4, 2017
CFN Interview with ABcann Medicinals
Interview with Aaron Keay
CFN Media Group - Wednesday October 4, 2017
ABcann Global Corporation Opens Toronto Stock Market
Ken Clement, Founder and Executive Chair and Aaron Keay, CEO, ABcann Global Corporation (ABCN), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange to open the market. ABcann Global is licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR).
TMX Group - Wednesday October 4, 2017
The strategic approach of ABcann’s growth technique
In this interview, Aaron Keay, CEO of ABcann Global Corporation, speaks with Natasha Frakes about why the company waited two years from getting their license before going public, the factors that differentiate the company from competitors, as well as their strategy in the Canadian marketplace. Aaron discusses how the company manages the health of its plants in order to ensure that deviation and variance in the product is minimal.
Market One Media Group Inc. - Wednesday October 4, 2017
Licensed producers negotiate learning curve to deliver consistent medical marijuana product
ABcann’s growing reputation for quality is opening doors abroad In Canada’s blossoming medical marijuana market, the field is rapidly becoming crowded.
BNN - Wednesday October 4, 2017
One Of The Earliest Licensed Medical Marijuana Producers
The growing cannabis sector is here to stay. We initiated on ABcann in May of this year. We really like the company for a few reasons, one they were one of the earliest licensed producers in the sector secondly, they’ve got a top-notch management team and lastly, their capacity potential.
B-TV - Wednesday October 4, 2017
Canadian Cannabis Facility Tours - ABcann Medicinals
Situated in Napanee, Ontario, ABcann’s belief is that clients deserve access to standardized medical cannabis that contributes to a balanced lifestyle. Our flagship facility contains exclusive plant growing technology combining together the concepts, systems and components to formulate a pharmaceutical grade, plant based medicine through standardization.
Lift - Wednesday September 22, 2017
ABcann Global Enters Its Growth Phase
CFN Media recently interviewed former CEO Aaron Keay to discuss the company’s transition and its long-term goals in the space
CFN - Wednesday September 20, 2017
ABcann aiming for Consistency
ABcann Global, a Canadian licensed medical marijuana producer, began trading on the Venture in May. We check in with Aaron Keay, CEO with ABcann Global, on how the company intends to scale up production.
BNN - Wednesday August 30, 2017
ABcann & Cannabis Wheaton Sign Win-Win Deal to Expand Production
CFN Media Group today announced publication of an article covering ABcann Global Corp.'s binding interim agreement with Cannabis Wheaton Income Corp.
CFN Media Group - Friday June 02, 2017
Time to Invest in ABcann Global (TSX-V: ABCN)
Some said it would be the biggest legal cannabis IPO of the year...
Wealth Daily - Wednesday May 31, 2017
ABcann’s Pesticide-Free Approach is a Breath of Fresh Air
The industry continues to struggle with safety concerns, such as the use of banned pesticides...
CFN Media Group - Tuesday May 23, 2017
Boom Time Ahead For Licensed Producers Of Medical Marijuana
ABcann Medicinals, one of Canada's first medical-marijuana producers to be licensed under federal regulations, is going public.
Financial Post - Friday. Mar. 17, 2017
Pharmaceutical Grade, Standardized Licensed Producer Poised to Go Public
Canada's legal cannabis industry could generate $22.6 billion in annual revenue, which has created significant opportunities for investors...
CFN Media Group - March, 2017
Cannabis Producer Growing
A Napanee company taking a high-tech approach to producing medical cannabis is going public in an effort to finance its rapid expansion...
Kingston Whig-Standard - February 17, 2017

ABcann Global Appoints New Independent Chair

October 17,2017

ABcann Global Receives $11.9 Million from Exercise of Warrants

September 18,2017

ABcann Global Appoints Barry Fishman as Chief Executive Officer

September 7,2017

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

August 30, 2017

ABcann Global files Q2 2017 Financial Results and Provides Operational Update

August 30, 2017

Management’s Discussion and Analysis

August 30, 2017

ABcann RELEASES HIGH LEVEL CBD PRODUCT AND LAUNCHES INITIAL OILS STRATEGY

August 28, 2017

ABcann GLOBAL PROVIDES CONSTRUCTION AND EXPANSION UPDATE

July 26, 2017

ABcann GLOBAL ANNOUNCES LISTING ON THE OTCQB MARKETPLACE AND THE FRANKFURT STOCK EXCHANGE

July 12, 2017

ABcann AND CANNABIS WHEATON ANNOUNCE SIGNING OF AGREEMENT FOR FIRST TRANCHE $15 MILLION INVESTMENT

July 10, 2017

ABcann GLOBAL ANNOUNCES INCLUSION ON THE HORIZONS MEDICAL MARIJUANA LIFE SCIENCES ETF

July 5, 2017

ABcann GLOBAL RECRUITS DR. MICHAEL SHANNON AS CHIEF MEDICAL CONSULTANT

June 29, 2017

ABcann GLOBAL EXTENDS RESEARCH AGREEMENT WITH THE UNIVERSITY OF GUELPH

June 26, 2017

ABcann GLOBAL AND CANNABIS WHEATON SIGN INTERIM AGREEMENT FOR CONSTRUCTION OF ADDITIONAL CANNABIS CULTIVATION FACILITY

May 29, 2017

ABcann GLOBAL ANNOUNCES APPOINTMENT OF W. BRETT WILSON TO ADVISORY BOARD

May 3, 2017

PANDA AND ABcann MEDICINALS ANNOUNCE MULTI-STAGE PRODUCT TESTING METHODOLOGY

April 24, 2017

PANDA AND ABcann MEDICINALS ANNOUNCE CONDITIONAL APPROVAL OF QUALIFYING TRANSACTION

March 30, 2017

PANDA AND ABcann MEDICINALS PROVIDE UPDATE ON QUALIFYING TRANSACTION AND ANNOUNCE $8 MILLION BROKERED FINANCING AND $15 MILLION NON-BROKERED FINANCING

March 23, 2017

PANDA ANNOUNCES PROPOSED QUALIFYING TRANSACTION WITH ABcann MEDICINALS INC

December 2, 2016
Read our: Abcann Global Corporation Corporate Governance Policies And Procedures | Code Of Business Conduct | Insider Trading Policy